A genome-wide scan for naevus count: linkage to CDKN2A and to other chromosome regions

被引:57
作者
Zhu, Gu
Montgomery, Grant W.
James, Michael R.
Trent, Jeff M.
Hayward, Nicholas K.
Martin, Nicholas G.
Duffy, David L. [1 ]
机构
[1] Royal Brisbane Hosp, Genet Epidemiol Lab, Queensland Inst Med Res, Brisbane, Qld, Australia
[2] Translat Genom Res Inst, Phoenix, AZ USA
关键词
naevus count; CDKN2A; linkage;
D O I
10.1038/sj.ejhg.5201729
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High numbers of melanocytic naevi (moles), and mutations in the p16 gene (CDKN2A), are two strong risk factors for cutaneous malignant melanoma. We have previously reported linkage of mole count to the CDKN2A locus. Here, we report genome-wide scans for mole counts (differentiated into flat, raised and atypical subtypes) with a total of 796 microsatellite markers for 424 families with 1024 twins and siblings, plus genotypes for 690 parents. Inclusion of 221 pairs of MZ twins enabled separation of shared environmental and polygenic influences, so placing an upper limit to estimates of QTL variance. Maximum likelihood multipoint variance component methods were used to assess linkage of naevus count. Sex, age, body surface area, skin colour, hair colour, sunburn and facial freckles were included as covariates. Peak linkage of flat mole count was to regions on chromosomes 2, 9, 8 and 17 with lod scores 2.95, 2.95, 2.50 and 2.15, respectively. The support for linkage to the CDKN2A gene region (9p21) increased to 3.42 when additional fine mapping markers were added. For raised mole count, there was suggestive evidence of linkage in our sample to chromosome 16 (lod = 1.87), and for atypical mole count on chromosomes 1, 6 and X with lod scores of 2.20, 2.00 and 2.00, respectively. The multivariate linkage peaks generally match those from individual trait analyses, with the exception of a new peak on chromosome 4 (point-wise empirical P-value = 0.001). We replicate our earlier finding of linkage to CDKN2A and discovering linkage to several novel regions that may also influence risk of the development of malignant melanoma.
引用
收藏
页码:94 / 102
页数:9
相关论文
共 62 条
  • [41] Mutation testing in melanoma families: INK4A, CDK4 and INK4D
    Newton-Bishop, JA
    Harland, M
    Bennett, DC
    Bataille, V
    Goldstein, AM
    Tucker, MA
    Ponder, BAJ
    Cuzick, J
    Selby, P
    Bishop, DT
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 (1-2) : 295 - 300
  • [42] Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype?
    Palmer, JS
    Duffy, DL
    Box, NF
    Aitken, JF
    O'Gorman, LE
    Green, AC
    Hayward, NK
    Martin, NG
    Sturm, RA
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (01) : 176 - 186
  • [43] BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma
    Patton, EE
    Widlund, HR
    Kutok, JL
    Kopani, KR
    Amatruda, JF
    Murphey, RD
    Berghmans, S
    Mayhall, EA
    Traver, D
    Fletcher, CDM
    Aster, JC
    Granter, SR
    Look, AT
    Lee, C
    Fisher, DE
    Zon, LI
    [J]. CURRENT BIOLOGY, 2005, 15 (03) : 249 - 254
  • [44] High frequency of BRAF mutations in nevi
    Pollock, PM
    Harper, UL
    Hansen, KS
    Yudt, LM
    Stark, M
    Robbins, CM
    Moses, TY
    Hostetter, G
    Wagner, U
    Kakareka, J
    Salem, G
    Pohida, T
    Heenan, P
    Duray, P
    Kallioniemi, O
    Hayward, NK
    Trent, JM
    Meltzer, PS
    [J]. NATURE GENETICS, 2003, 33 (01) : 19 - 20
  • [45] R Development Core Team, R LANG ENV STAT COMP
  • [46] Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men
    Rennert, H
    Zeigler-Johnson, CM
    Addya, K
    Finley, MJ
    Walker, AH
    Spangler, E
    Leonard, DGB
    Wein, A
    Malkowicz, SB
    Rebbeck, TR
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (04) : 949 - 957
  • [47] Human acquired naevi are clonal
    Robinson, WA
    Lemon, M
    Elefanty, A
    Harrison-Smith, M
    Markham, N
    Norris, D
    [J]. MELANOMA RESEARCH, 1998, 8 (06) : 499 - 503
  • [48] SIEMENS HW, 1925, ZWILLINGSPATHOLOGIE
  • [49] BRAF mutation predicts sensitivity to MEK inhibition
    Solit, DB
    Garraway, LA
    Pratilas, CA
    Sawai, A
    Getz, G
    Basso, A
    Ye, Q
    Lobo, JM
    She, YH
    Osman, I
    Golub, TR
    Sebolt-Leopold, J
    Sellers, WR
    Rosen, N
    [J]. NATURE, 2006, 439 (7074) : 358 - 362
  • [50] MELANOCYTIC NEVI AND MELANOMA - AN EPIDEMIOLOGIC PERSPECTIVE
    SWERDLOW, AJ
    GREEN, A
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1987, 117 (02) : 137 - 146